Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study To Find Out How Fesoterodine Works In Children Aged 6 To 17 Years With Bladder Overactivity Caused By A Neurological Condition

ClinicalTrials.gov ID: NCT01557244

Public ClinicalTrials.gov record NCT01557244. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 7:30 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A 24-WEEK RANDOMIZED, OPEN-LABEL, STUDY TO EVALUATE THE SAFETY AND EFFICACY OF FESOTERODINE IN SUBJECTS AGED 6 TO 17 YEARS WITH SYMPTOMS OF DETRUSOR OVERACTIVITY ASSOCIATED WITH A NEUROLOGICAL CONDITION (NEUROGENIC DETRUSOR OVERACTIVITY)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The objective of the study is to find out if the medicine fesoterodine is a useful treatment in children with bladder muscle overactivity caused by a neurological condition. Children will be aged 6 to 17 years old. This is done by finding out how well it works, what the body does to fesoterodine, what side effects are experienced and the safety of fesoterodine. It will be compared with the medicine oxybutynin, which is already available for treating the condition.

Study identification

NCT ID
NCT01557244
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Pfizer
Industry
Enrollment
181 participants

Conditions and interventions

Eligibility (public fields only)

Age range
6 Years to 17 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 2, 2012 (Actual)
Primary completion
Nov 7, 2019 (Actual)
Completion
Feb 13, 2020 (Actual)
Last update posted
Feb 2, 2021

2012 – 2020

United States locations

U.S. sites
18
U.S. states
9
U.S. cities
11
Facility City State ZIP Site status
Urological Associates of Southern Arizona Tucson Arizona 85715 —
Childrens Hospital of Orange County Orange California 92868 —
CHOC Children's Urology Center Orange California 92868 —
Children's Healthcare of Atlanta Atlanta Georgia 30342 —
Georgia Urology, P.A. Atlanta Georgia 30342 —
Judson L. Hawk Jr. M.D. Atlanta Georgia 30342 —
Loyola University Medical Center Maywood Illinois 60153 —
Loyola University Outpatient Center Maywood Illinois 60153 —
The Iowa Clinic West Des Moines Iowa 50266 —
UNC Chapel Hill Memorial Hospital Chapel Hill North Carolina 27514 —
UNC Memorial Hospital Pediatric Clinic Chapel Hill North Carolina 27514 —
Cincinnati Children's Hospital Medical Center Cincinnati Ohio 45229 —
Cincinnati Children's Hospital Medical Center Liberty Township Ohio 45044 —
Advanced Radiology East Providence Rhode Island 02914 —
Pharma Resource East Providence Rhode Island 02915 —
University Urological Associates, Inc Providence Rhode Island 02904 —
University Urological Associates, Inc. Providence Rhode Island 02905 —
Children's Hospital of Wisconsin Milwaukee Wisconsin 53226 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 66 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01557244, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 2, 2021 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01557244 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →